Lenvatinib and pembrolizumab plus FOLFOX-hepatic arterial infusion chemotherapy in locally advanced, potentially resectable hepatocellular carcinoma

Table 2 Baseline characteristics of 38 patients who had primary unresectable hepatocellular carcinoma

Clinical characteristic	Data
Sex
Male	36
Female	2
Age (years)
≤ 65	32
> 65	6
Hepatitis B
Yes	34
No	4
Cirrhosis
Yes	18
No	20
Antiviral treatment
Yes	8
No	30
China Liver Cancers stage
Ia	1
Ib	5
IIa	3
IIb	1
IIIa	28
Barcelona Clinic Liver Cancer stage
Early (A)	6
Intermediate (B)	4
Advanced (C)	28
Number of cancer lesions
1	16
≥ 2	22
Sum of longest diameter of target lesions (cm)
≥ 10	23
< 10	15
Alpha-fetoprotein (μg/L)
≥ 400	21
< 400	17